Relevant presentations, workshops and posters by current and former members of the StarDrop team. Take a look at the community pages to see copies of the various publications and presentations we've published.
Presentations
- Obrezanova O, Segall MD. Automated QSAR Modeling to Guide Drug Design. ACS National Meeting. Spring 2009, Salt Lake City, UT, USA.
- Obrezanova O, Segall MD, Gola JMR, Champness EJ. Automated QSAR Modeling to Guide Drug Design. Zing Computational Chemistry Meeting. March 2009, Antigua.
- Obrezanova O, Gola JMR, Champness EJ, Segall MD. Automatic QSAR Modeling of Blood-Brain Barrier Penetration by Gaussian Processes Method. eCheminfo Latest Advances in Drug Discovery Informatics. October 2008, Philadelphia.
- Segall MD. Multiparameter Optimisation: Achieving Balance with Confidence. MipTec. October 2008, Basel, Switzerland.
- Segall MD. ADMET Optimization and in Silico Drug Discovery. IBM Life Sciences Modeling & Simulation Summit. September 2008, Amagi Homestead, Japan.
- Segall MD. Turning uncertain, multivariate data into effective decisions. AAPS Drug Discovery Strategies and Critical Issues for Clinical Candidate Selection. May 2008, South San Francisco.
- Segall MD. From Drug Discovery to Drug Design: Uncertain models to certain success? ADMET Europe. February 2008, Stockholm, Sweden.
- Segall MD. From Drug Discovery to Drug Design: Uncertain models to certain success? ACS Western Regional Meeting. October 2007, San Diego.
- Obrezanova O, Gola J, Segall M. Gaussian Processes: A method for automatic QSAR and ADME modelling. ACS Autumn Meeting. August 2007, Boston.
- Beresford A. Predictive ADME Models in Drug Discovery: Can You Trust Them? Can You Afford Not To? Med Chem USA. October 2007, Boston, MA, USA.
- Obrezanova O, Gola J, Segall M. Gaussian Processes: A method for automatic QSAR and ADME modelling. UK QSAR. October 2007, Stevenage, UK.
- Gola JMR, Obrezanova O. Automatic Model Generation. June 2007, Sheffield, UK.
- Segall MD. The Journey from Drug Discovery to Drug Design: How far have we travelled? SMI in Silico ADMET. May 2007, London.
- Champness E. Opening the "black box": Interpreting in silico models to guide compound design. ACS Spring Meeting. March 2007, Chicago.
- Segall MD. Why are we Still Doing Drug Discovery? ACS Spring Meeting. March 2007, Chicago.
- Beresford AP. ADME Screening: High Throughput vs High Intelligence. Med Chem Europe. February 2007, Barcelona.
Workshops
- Olga Obrezanova lead a session on "Building QSAR models to Guide Drug Design" at the Predictive ADME and Toxicology Workshop, eCheminfo, Oxford, UK, 27th-31st July 2009.
- Matt Segall presented a session titled "Enabling Interactive Multi-Objective Optimization for Drug Discovery Scientists" at the Lorentz Workshop - Optimizing Drug Design, Lorentz Centre, Leiden, The Netherlands, 21st-23rd July 2009.
Posters
- McCormick D, Champness E, Gola J. Application of in Silico (ADMEnsa Interactive) and ADME/PK Assays in the Identification of New Chemical Entities(NCEs) for Pre-Clinical Evaluation ISSX Japan. October 2007, Sendai, Japan. (Poster)
- Segall MD, Champness E. Opening the 'Black Box': Interpreting in Silico Models to Guide Compound Design. Med Chem Europe. February 2007, Barcelona.
